檢索結果 - Takuma Miura

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Solid Tumors

    First-in-Human Phase 1 Study of MORAb-202, an Antibody–Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α–Positive Advanced Soli... 由 Toshio Shimizu, Yutaka Fujiwara, Kan Yonemori, Takafumi Koyama, Jun Sato, Kenji Tamura, Akihiko Shimomura, Hiroki Ikezawa, Maiko Nomoto, Keiji Furuuchi, Ryo Nakajima, Takuma Miura, Noboru Yamamoto

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Early introduction of very small amounts of multiple foods to infants: A randomized trial

    Early introduction of very small amounts of multiple foods to infants: A randomized trial 由 Tatsuo Nishimura, Mitsuru Fukazawa, Keisuke Fukuoka, Teruo Okasora, Shinichi Yamada, Shigeharu Kyo, Makoto Homan, Takuma Miura, Yasuyuki Nomura, Shinya Tsuchida, Shigehiro Yajima, Satoshi Aoki, Yutaka Nakamura, Taisuke Hosaka, Hirokazu Hidaka, Hiroyuki Yamamori, Akira Inoue, Jiro Morimoto

    出版 2022
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease

    Patients with Epstein–Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease 由 Takashi Sekine, Mutsuko Konno, Satoshi Sasaki, Suzuko Moritani, Takuma Miura, Wai-shan Wong, Hisanori Nishio, Toshihiro Nishiguchi, Miyako Yoshinari Ohuchi, Shigeru Tsuchiya, Takeshi Matsuyama, Hirokazu Kanegane, Komei Ida, Kenichiro Miura, Yutaka Harita, Motoshi Hattori, Shigeru Horita, Takashi Igarashi, Hidehiko Saito, Shinji Kunishima

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

    Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advan... 由 Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa, Mayu Yunokawa, Kimio Ushijima, Shiro Suzuki, Ayumi Shikama, Shinichiro Minobe, Tomoka Usami, Jae‐Weon Kim, Byoung‐Gie Kim, Peng‐Hui Wang, Ting‐Chang Chang, Keiko Yamamoto, Shirong Han, Jodi A. McKenzie, Robert Orlowski, Takuma Miura, Vicky Makker, Yong Man Kim

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: